Hemodynamic Effects of Epoprostenol in Patients With Systemic Sclerosis and Pulmonary Hypertension

This publication has 32 references indexed in Scilit:

• Lung Disease in Systemic Sclerosis (Scleroderma)
  Seminars in Respiratory and Critical Care Medicine, 1999
• Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring
  Thorax, 1998
• Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension
  New England Journal of Medicine, 1998
• Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients
  Rheumatology, 1996
• Density gradient of the lung parenchyma at computed tomographic scanning in patients with pulmonary hypertension and systemic sclerosis
  Academic Radiology, 1996
• Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve.
  Annals of the Rheumatic Diseases, 1996
• Noninvasive Evaluation Of Right Ventricle Systolic Pressure During Dynamic Exercise by Saline-Enhanced Doppler Echocardiography in Progressive Systemic Sclerosis
  Angiology, 1996
• Atteintes cardiaques au cours des sclérodermies: étude en écho-cardiographie et doppler cardiaque chez 38 patients
  La Revue de Médecine Interne, 1993
• Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease
  The American Journal of Cardiology, 1991
• Pulmonary hypertension in the crest syndrome variant of systemic sclerosis
  Arthritis & Rheumatism, 1986